ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Alzheimer’s Ecosystem Manager at Eli Lilly and Company - ApplyBlast

Alzheimer’s Ecosystem Manager

Eli Lilly and Company

3 months ago

4.0 on Glassdoor

Gurgaon, Haryana, India

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The role focuses on mapping and developing strategies for priority accounts in the Alzheimer’s disease ecosystem, engaging stakeholders, and building capabilities to ensure timely diagnosis and appropriate care pathways. It involves ecosystem readiness, partnership development, and tracking performance against defined KPIs to minimize patient leakage.

Responsibilities

Develop and execute account mapping and strategy for priority accounts
Engage stakeholders and maintain cross‑functional account plans using Veeva
Build and monitor AD diagnostic ecosystem readiness and strategic partnerships

Skills

Qualifications

Bachelor's degree in Business Administration or Pharmaceutical Sciences

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.